Facebook
Twitter
Telegram
Report an ErrorSigilon Therapeutics Income Statement 2011-2024 | SGTX
Annual Income Statement Sigilon Therapeutics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
39.9 M | 46.2 M | 405 M | - | - | - | - | - | - | - | - | - |
Shares |
32.4 M | 31.9 M | 13.2 M | - | - | - | - | - | - | - | - | - |
Historical Prices |
1.23 | 1.45 | 26.6 | - | - | - | - | - | - | - | - | - |
Net Income |
-43.6 M | -77.3 M | -54.6 M | -43.9 M | -22.8 M | - | - | - | - | - | - | - |
Revenue |
12.9 M | 9.6 M | 13.4 M | 14.2 M | 4.64 M | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | 13.4 K | - | - | - | - | - | - | - | - | - |
Operating Income |
-43.7 M | -75.6 M | -52.6 M | - | - | - | - | - | - | - | - | - |
Interest Expense |
2.29 M | 1.99 M | 1.2 M | - | - | - | - | - | - | - | - | - |
EBITDA |
-42.4 M | -74.5 M | -51.8 M | -43.4 M | -22.7 M | - | - | - | - | - | - | - |
Operating Expenses |
56.6 M | 85.2 M | 66 M | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
19 M | 20.2 M | 12.5 M | 10.2 M | 6.67 M | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Sigilon Therapeutics
| 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
2.5 M | 32.5 M | 2.5 M | 32.4 M | 2.49 M | 32.4 M | 32.4 M | 32.1 M | 31.6 M | 31.5 M | 31.5 M | 5.34 M | 5.32 M | 4.98 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-7.51 M | -7.38 M | - | -8.67 M | -14.3 M | -13.9 M | - | -20.2 M | -20.4 M | -19 M | - | -54.6 M | -54.6 M | -54.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
5.9 M | 4.86 M | - | 4.25 M | 2.88 M | 3.16 M | - | 1.95 M | 2.7 M | 2.96 M | - | 4.2 M | 1.95 M | 3.47 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-7.44 M | -7.25 M | - | -8.42 M | -14 M | -13.5 M | - | -19.7 M | -20 M | -18.6 M | - | -12.6 M | -13.3 M | -12.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
310 K | 611 K | - | 606 K | 543 K | 491 K | - | 499 K | 494 K | 488 K | - | 293 K | 196 K | 208 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-7.14 M | -6.93 M | - | -8.12 M | -13.7 M | -13.2 M | - | -19.4 M | -19.7 M | -18.3 M | - | -12.4 M | -13.1 M | -12.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
13.3 M | 12.1 M | - | 12.7 M | 16.9 M | 16.6 M | - | 21.7 M | 22.7 M | 21.5 M | - | 16.8 M | 15.3 M | 16.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
5.88 M | 4.32 M | - | 4.4 M | 5.04 M | 5.02 M | - | 5.04 M | 4.99 M | 5.54 M | - | 3.33 M | 2.82 M | 2.87 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency